Prostate‐specific membrane antigen expression in melanoma metastases-Reference-Cited by-同舟云学术

Prostate‐specific membrane antigen expression in melanoma metastases

Published:2020-07-06 Issue:12 Volume:47 Page:1115-1122
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Snow Hayden¹^ORCID,Hazell Stephen²,Francis Nicholas³,Mohammed Kabir⁴,O'Neill Stephanie¹,Davies Emma⁵,Mansfield David⁵,Messiou Christina⁵⁶,Hujairi Nabil⁶,Nicol David⁷,Harrington Kevin⁵,Smith Myles¹

Affiliation:

1. Department of Academic Surgery, Melanoma and Sarcoma The Royal Marsden NHS Foundation Trust London UK

2. Department of Histopathology The Royal Marsden NHS Foundation Trust London UK

3. North West London Pathology Imperial College Healthcare NHS Trust London UK

4. Clinical Research and Development Department The Royal Marsden NHS Foundation Trust London UK

5. Targeted Therapy Team The Institute of Cancer Research London UK

6. Department of Diagnostic Radiology The Royal Marsden NHS Foundation Trust London UK

7. Department of Academic Surgery, Urology The Royal Marsden NHS Foundation Trust London UK

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cup.13774

Reference35 articles.

1. Prostate‐specific membrane antigen expression in normal and malignant human tissues;Silver DA;Clin Cancer Res,1997

2. 68Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis

3. Assessment of Bone Metastases in Patients with Prostate Cancer—A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT

4. Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

5. A comparative study of 68Gallium-prostate specific membrane antigen positron emission tomography-computed tomography and magnetic resonance imaging for lymph node staging in high risk prostate cancer patients: An initial experience

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple Primary Malignancy Detection in an Elderly Male: A Case Report on Concurrent Prostate Cancer, Clear Cell Renal Cell Carcinoma, and Metastatic Melanoma Identified by PSMA PET-CT;Urology Case Reports;2024-07

2. Prostataspezifisches Membranantigen (PSMA)‐exprimierende Melanommetastasen bei einem Patienten mit Prostatakarzinom und Melanom;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-03

3. Prostate‐specific membrane antigen (PSMA)‐expressing melanoma metastases in a patient with prostate cancer and melanoma;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-02-25

4. Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1);Frontiers in Medicine;2024-02-09

5. Malignant melanoma of the prostate: Primary or metastasis? A case report;World Journal of Clinical Cases;2023-08-26